OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In so...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Butler, David Charles Donnell, Francis, Christopher J, Lu, Genliang, Meena, Verdine, Gregory L, Iwamoto, Naoki, Zhang, Jason Jingxin, Frank-Kamenetsky, Maria David, Vargeese, Chandra, Divakaramenon, Sethumadhavan, Marappan, Subramanian, Yang, Hailin
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Butler, David Charles Donnell
Francis, Christopher J
Lu, Genliang
Meena
Verdine, Gregory L
Iwamoto, Naoki
Zhang, Jason Jingxin
Frank-Kamenetsky, Maria David
Vargeese, Chandra
Divakaramenon, Sethumadhavan
Marappan, Subramanian
Yang, Hailin
description Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024117347A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024117347A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024117347A13</originalsourceid><addsrcrecordid>eNrjZDDw9_F09_cLdfZx9Q_xdHFVcPb3DfAP9gzx9PcLVnD0c1HwdQ3x8HcJVgjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmhobmxibmjobGxKkCAPEzJ4o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF</title><source>esp@cenet</source><creator>Butler, David Charles Donnell ; Francis, Christopher J ; Lu, Genliang ; Meena ; Verdine, Gregory L ; Iwamoto, Naoki ; Zhang, Jason Jingxin ; Frank-Kamenetsky, Maria David ; Vargeese, Chandra ; Divakaramenon, Sethumadhavan ; Marappan, Subramanian ; Yang, Hailin</creator><creatorcontrib>Butler, David Charles Donnell ; Francis, Christopher J ; Lu, Genliang ; Meena ; Verdine, Gregory L ; Iwamoto, Naoki ; Zhang, Jason Jingxin ; Frank-Kamenetsky, Maria David ; Vargeese, Chandra ; Divakaramenon, Sethumadhavan ; Marappan, Subramanian ; Yang, Hailin</creatorcontrib><description>Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DERIVATIVES THEREOF ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; SUGARS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240411&amp;DB=EPODOC&amp;CC=US&amp;NR=2024117347A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240411&amp;DB=EPODOC&amp;CC=US&amp;NR=2024117347A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Butler, David Charles Donnell</creatorcontrib><creatorcontrib>Francis, Christopher J</creatorcontrib><creatorcontrib>Lu, Genliang</creatorcontrib><creatorcontrib>Meena</creatorcontrib><creatorcontrib>Verdine, Gregory L</creatorcontrib><creatorcontrib>Iwamoto, Naoki</creatorcontrib><creatorcontrib>Zhang, Jason Jingxin</creatorcontrib><creatorcontrib>Frank-Kamenetsky, Maria David</creatorcontrib><creatorcontrib>Vargeese, Chandra</creatorcontrib><creatorcontrib>Divakaramenon, Sethumadhavan</creatorcontrib><creatorcontrib>Marappan, Subramanian</creatorcontrib><creatorcontrib>Yang, Hailin</creatorcontrib><title>OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF</title><description>Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDw9_F09_cLdfZx9Q_xdHFVcPb3DfAP9gzx9PcLVnD0c1HwdQ3x8HcJVgjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmhobmxibmjobGxKkCAPEzJ4o</recordid><startdate>20240411</startdate><enddate>20240411</enddate><creator>Butler, David Charles Donnell</creator><creator>Francis, Christopher J</creator><creator>Lu, Genliang</creator><creator>Meena</creator><creator>Verdine, Gregory L</creator><creator>Iwamoto, Naoki</creator><creator>Zhang, Jason Jingxin</creator><creator>Frank-Kamenetsky, Maria David</creator><creator>Vargeese, Chandra</creator><creator>Divakaramenon, Sethumadhavan</creator><creator>Marappan, Subramanian</creator><creator>Yang, Hailin</creator><scope>EVB</scope></search><sort><creationdate>20240411</creationdate><title>OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF</title><author>Butler, David Charles Donnell ; Francis, Christopher J ; Lu, Genliang ; Meena ; Verdine, Gregory L ; Iwamoto, Naoki ; Zhang, Jason Jingxin ; Frank-Kamenetsky, Maria David ; Vargeese, Chandra ; Divakaramenon, Sethumadhavan ; Marappan, Subramanian ; Yang, Hailin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024117347A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>Butler, David Charles Donnell</creatorcontrib><creatorcontrib>Francis, Christopher J</creatorcontrib><creatorcontrib>Lu, Genliang</creatorcontrib><creatorcontrib>Meena</creatorcontrib><creatorcontrib>Verdine, Gregory L</creatorcontrib><creatorcontrib>Iwamoto, Naoki</creatorcontrib><creatorcontrib>Zhang, Jason Jingxin</creatorcontrib><creatorcontrib>Frank-Kamenetsky, Maria David</creatorcontrib><creatorcontrib>Vargeese, Chandra</creatorcontrib><creatorcontrib>Divakaramenon, Sethumadhavan</creatorcontrib><creatorcontrib>Marappan, Subramanian</creatorcontrib><creatorcontrib>Yang, Hailin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Butler, David Charles Donnell</au><au>Francis, Christopher J</au><au>Lu, Genliang</au><au>Meena</au><au>Verdine, Gregory L</au><au>Iwamoto, Naoki</au><au>Zhang, Jason Jingxin</au><au>Frank-Kamenetsky, Maria David</au><au>Vargeese, Chandra</au><au>Divakaramenon, Sethumadhavan</au><au>Marappan, Subramanian</au><au>Yang, Hailin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF</title><date>2024-04-11</date><risdate>2024</risdate><abstract>Among other things, the present disclosure relates to designed oligonucleotides, compositions, and methods thereof. In some embodiments, provided oligonucleotide compositions provide altered splicing of a transcript. In some embodiments, provided oligonucleotide compositions have low toxicity. In some embodiments, provided oligonucleotide compositions provide improved protein binding profiles. In some embodiments, provided oligonucleotide compositions have improved delivery. In some embodiments, provided oligonucleotide compositions have improved uptake. In some embodiments, the present disclosure provides methods for treatment of diseases using provided oligonucleotide compositions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024117347A1
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
title OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T19%3A40%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Butler,%20David%20Charles%20Donnell&rft.date=2024-04-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024117347A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true